Smart device alerts aim to cut heart failure hospitalizations

NCT ID NCT06099158

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether using alerts from a heart device (HeartLogic) can help manage heart failure better. About 1,428 adults with a compatible implanted device will be randomly assigned to have their care guided by these alerts or not. The goal is to see if this approach reduces hospitalizations for heart failure or death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HeartLogic alert management (a software feature in implanted cardiac devices that provides alerts to guide heart failure care)
What this could lead to
If it works, this could provide a better way to manage heart failure using device alerts, potentially reducing hospital stays and improving survival.
What could go wrong
This is a pragmatic trial, so results may vary in real-world settings. The intervention is a monitoring tool, not a treatment, so benefits may be modest or not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte

    RECRUITING

    Hellerup, Capital Region, 2900, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.